|
THEO-260 Clinical Trials
2 actively recruiting trials across 1 location
Pipeline
Phase 1: 1Phase 1/2: 1
Top Sponsors
- Theolytics Limited2
Indications
- Ovarian Cancer2
- Cancer2
Other1 trial
Houston, Texas1 trial
Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
MD Anderson Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.